Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy

Overview of attention for article published in Stroke, June 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 11 news outlets
blogs: 3 blogs

twitter: 4 X users

Readers on

mendeley: 47 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,935 followers.

Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy - PubMed https://t.co/xoJdeMupDJ

RT @AmgadMentias: Our study in Stroke journal about comparative effectiveness and safety of rivaroxaban, apixaban, and warfarin in AF patie…

Our study in Stroke journal about comparative effectiveness and safety of rivaroxaban, apixaban, and warfarin in AF patients with polypharmacy. Polypharmacy is prevalent in AF patients and affects outcomes including stroke, bleeding and mortality. http…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.